Share on StockTwits

Neuralstem (NYSE:CUR) Director William Clyde Oldaker acquired 15,235 shares of Neuralstem stock in a transaction dated Monday, May 5th. The shares were purchased at an average price of $3.50 per share, for a total transaction of $53,322.50. Following the purchase, the director now directly owns 116,939 shares in the company, valued at approximately $409,287. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Neuralstem (NYSE:CUR) traded down 7.08% on Wednesday, hitting $3.15. The stock had a trading volume of 1,171,159 shares. Neuralstem has a 52-week low of $1.18 and a 52-week high of $4.80. The stock has a 50-day moving average of $3.99 and a 200-day moving average of $3.23. The company’s market cap is $271.6 million.

Neuralstem (NYSE:CUR) last posted its quarterly earnings results on Monday, March 10th. The company reported ($0.04) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.06) by $0.02. Analysts expect that Neuralstem will post $-0.22 EPS for the current fiscal year.

Neuralstem, Inc is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.